L. Mannucci et al., ONE MONTH FOLLOW-UP OF HEMOSTATIC VARIABLES IN PATIENTS UNDERGOING AORTOCORONARY BYPASS-SURGERY - EFFECT OF APROTININ, Thrombosis and haemostasis, 73(3), 1995, pp. 356-361
It is already known that activation of the coagulation and fibrinolyti
c system occurs in patients undergoing cardiopulmonary bypass (CPB). W
e have thus studied twenty patients (10 treated with aprotinin during
CPB and 10 untreated) both during the intraoperative period and during
thirty days follow up. In untreated patients D-dimer levels increased
4-fold during CPB and the levels were above baseline for the whole fo
llow up (p<0.0001). D-dimer levels were reduced in aprotinin treated p
atients in comparison to untreated patients (p = 0.0172); levels then
gradually increased to the values of the untreated patients over the f
ollowing 24 h later and remained higher during the thirty day follow u
p. The behavior of haemostatic variables in the 24 h after CPB did not
vary between untreated and aprotinin treated patients. In particular,
five minutes after protamine sulphate administration, levels of F1 2 and TAT rose significantly (p = 0.0054, p = 0.0022 respectively), wh
ereas fibrinogen significantly decreased (p<0.0001) and PAI-1 antigen
levels were reduced. Two days after CPB the concentrations of F1 + 2 a
nd TAT lowered, whereas fibrinogen and PAI-1 antigen levels increased.
On the 5th, 8th and 30th days after CPB, F1 + 2 and TAT levels remain
ed higher than those reported at baseline in both groups of patients,
whereas fibrinogen levels increased over basal levels in aprotinin tre
ated patients only. Thus, in addition to the activation of the coagula
tion and fibrinolytic system occurring during the intraoperative perio
d, in patients undergoing CPB, there are alterations of haemostatic va
riables up to thirty days from surgery.